SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. You have free access to this content1
    Jade Ghosn, Baptiste Fouquet, Yann Quertainmont, Dominique Salmon, Sabrinel Sahali, Christophe Rioux, Claudine Duvivier, Martine Mole, Jean-François Delfraissy, Micheline Misrahi, Claudin-1 gene variants and susceptibility to hepatitis C infection in HIV-1 infected intravenous drug users (an ANRS case-control study), Journal of Medical Virology, 2015, 87, 4
  2. 2
    Rajiv G. Tawar, Che C. Colpitts, Joachim Lupberger, Hussein El-Saghire, Mirjam B. Zeisel, Thomas F. Baumert, Claudins and pathogenesis of viral infection, Seminars in Cell & Developmental Biology, 2015,

    CrossRef

  3. 3
    Laurent Mailly, Fei Xiao, Joachim Lupberger, Garrick K Wilson, Philippe Aubert, François H T Duong, Diego Calabrese, Céline Leboeuf, Isabel Fofana, Christine Thumann, Simonetta Bandiera, Marc Lütgehetmann, Tassilo Volz, Christopher Davis, Helen J Harris, Christopher J Mee, Erika Girardi, Béatrice Chane-Woon-Ming, Maria Ericsson, Nicola Fletcher, Ralf Bartenschlager, Patrick Pessaux, Koen Vercauteren, Philip Meuleman, Pascal Villa, Lars Kaderali, Sébastien Pfeffer, Markus H Heim, Michel Neunlist, Mirjam B Zeisel, Maura Dandri, Jane A McKeating, Eric Robinet, Thomas F Baumert, Clearance of persistent hepatitis C virus infection in humanized mice using a claudin-1-targeting monoclonal antibody, Nature Biotechnology, 2015, 33, 5, 549

    CrossRef

  4. 4
    Radwa Yehia Mekky, Nada Magdy El-Ekiaby, Mohammed Tarif Hamza, Noha Mousaad Elemam, Mohammed EL-sayed, Gamal Esmat, Ahmed Ihab Abdelaziz, Mir-194 is a hepatocyte gate keeper hindering HCV entry through targeting CD81 receptor, Journal of Infection, 2015, 70, 1, 78

    CrossRef

  5. 5
    Sharon E. Hopcraft, Matthew J. Evans, Selection of a hepatitis C virus with altered entry factor requirements reveals a genetic interaction between the E1 glycoprotein and claudins, Hepatology, 2015, 61, 6
  6. 6
    Che C. Colpitts, Eloi R. Verrier, Thomas F. Baumert, Targeting Viral Entry for Treatment of Hepatitis B and C Virus Infections, ACS Infectious Diseases, 2015, 150518095956001

    CrossRef

  7. 7
    Sarah C Ogden, Hengli Tang, The missing pieces of the HCV entry puzzle, Future Virology, 2015, 10, 4, 415

    CrossRef

  8. 8
    Isabel Fofana, Nikolaus Jilg, Raymond T. Chung, Thomas F. Baumert, Entry inhibitors and future treatment of hepatitis C, Antiviral Research, 2014, 104, 136

    CrossRef

  9. 9
    Juliane Doerrbecker, Martina Friesland, Nina Riebesehl, Corinne Ginkel, Patrick Behrendt, Richard J.P. Brown, Sandra Ciesek, Heiner Wedemeyer, Christoph Sarrazin, Lars Kaderali, Thomas Pietschmann, Eike Steinmann, Incorporation of primary patient-derived glycoproteins into authentic infectious hepatitis C virus particles, Hepatology, 2014, 60, 2
  10. 10
    Qiang Ding, Markus von Schaewen, Alexander Ploss, The Impact of Hepatitis C Virus Entry on Viral Tropism, Cell Host & Microbe, 2014, 16, 5, 562

    CrossRef

  11. 11
    Gisa Gerold, Thomas Pietschmann, Opportunities and Risks of Host-targeting Antiviral Strategies for Hepatitis C, Current Hepatitis Reports, 2013, 12, 4, 200

    CrossRef